The epidemiology of HIV and HSV-2 infections among women participating in microbicide and vaccine feasibility studies in Northern Tanzania.

To prepare for future HIV prevention trials, we conducted prospective cohort studies among women working in food and recreational facilities in northern Tanzania. We examined the prevalence and incidence of HIV and HSV-2, and associated risk factors.Women aged 18-44 years working in food and recreat...

Full description

Bibliographic Details
Main Authors: Saidi H Kapiga, Fiona M Ewings, Tony Ao, Joseph Chilongani, Aika Mongi, Kathy Baisley, Suzanna Francis, Aura Andreasen, Ramadhan Hashim, Deborah Watson-Jones, John Changalucha, Richard Hayes
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3715536?pdf=render
id doaj-77c9f1158d3349c0a9514841199a5ad1
record_format Article
spelling doaj-77c9f1158d3349c0a9514841199a5ad12020-11-25T01:30:48ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0187e6882510.1371/journal.pone.0068825The epidemiology of HIV and HSV-2 infections among women participating in microbicide and vaccine feasibility studies in Northern Tanzania.Saidi H KapigaFiona M EwingsTony AoJoseph ChilonganiAika MongiKathy BaisleySuzanna FrancisAura AndreasenRamadhan HashimDeborah Watson-JonesJohn ChangaluchaRichard HayesTo prepare for future HIV prevention trials, we conducted prospective cohort studies among women working in food and recreational facilities in northern Tanzania. We examined the prevalence and incidence of HIV and HSV-2, and associated risk factors.Women aged 18-44 years working in food and recreational facilities were screened to determine their eligibility for the studies. Between 2008-2010, HIV-negative women were enrolled and followed for 12 months. At enrolment and 3-monthly, we collected socio-demographic and behavioural data, and performed clinical examinations for collection of biological specimens that were tested for reproductive tract infections. Risk factors for HIV and HSV-2 incidence were investigated using Poisson regression models.We screened 2,229 and enrolled 1,378 women. The median age was 27 years (interquartile range, IQR 22, 33), and median duration working at current facility was 2 years. The prevalences of HIV at screening and HSV-2 at enrolment were 16% and 67%, respectively. Attendance at the 12-month visit was 86%. HIV and HSV-2 incidence rates were 3.7 (95% confidence interval, CI: 2.8,5.1) and 28.6 (95% CI: 23.5,35.0)/100 person-years, respectively. Women who were separated, divorced, or widowed were at increased risk of HIV (adjusted incidence rate ratio, aRR = 6.63; 95% CI: 1.97,22.2) and HSV-2 (aRR = 2.00; 95% CI: 1.15,3.47) compared with married women. Women reporting ≥3 partners in the past 3 months were at higher HIV risk compared with women with 0-1 partner (aRR = 4.75; 95% CI: 2.10,10.8), while those who had reached secondary education or above were at lower risk of HSV-2 compared with women with incomplete primary education (aRR = 0.42; 95% CI: 0.22,0.82).HIV and HSV-2 rates remain substantially higher in this cohort than in the general population, indicating urgent need for effective interventions. These studies demonstrate the feasibility of conducting trials to test new interventions in this highly-mobile population.http://europepmc.org/articles/PMC3715536?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Saidi H Kapiga
Fiona M Ewings
Tony Ao
Joseph Chilongani
Aika Mongi
Kathy Baisley
Suzanna Francis
Aura Andreasen
Ramadhan Hashim
Deborah Watson-Jones
John Changalucha
Richard Hayes
spellingShingle Saidi H Kapiga
Fiona M Ewings
Tony Ao
Joseph Chilongani
Aika Mongi
Kathy Baisley
Suzanna Francis
Aura Andreasen
Ramadhan Hashim
Deborah Watson-Jones
John Changalucha
Richard Hayes
The epidemiology of HIV and HSV-2 infections among women participating in microbicide and vaccine feasibility studies in Northern Tanzania.
PLoS ONE
author_facet Saidi H Kapiga
Fiona M Ewings
Tony Ao
Joseph Chilongani
Aika Mongi
Kathy Baisley
Suzanna Francis
Aura Andreasen
Ramadhan Hashim
Deborah Watson-Jones
John Changalucha
Richard Hayes
author_sort Saidi H Kapiga
title The epidemiology of HIV and HSV-2 infections among women participating in microbicide and vaccine feasibility studies in Northern Tanzania.
title_short The epidemiology of HIV and HSV-2 infections among women participating in microbicide and vaccine feasibility studies in Northern Tanzania.
title_full The epidemiology of HIV and HSV-2 infections among women participating in microbicide and vaccine feasibility studies in Northern Tanzania.
title_fullStr The epidemiology of HIV and HSV-2 infections among women participating in microbicide and vaccine feasibility studies in Northern Tanzania.
title_full_unstemmed The epidemiology of HIV and HSV-2 infections among women participating in microbicide and vaccine feasibility studies in Northern Tanzania.
title_sort epidemiology of hiv and hsv-2 infections among women participating in microbicide and vaccine feasibility studies in northern tanzania.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2013-01-01
description To prepare for future HIV prevention trials, we conducted prospective cohort studies among women working in food and recreational facilities in northern Tanzania. We examined the prevalence and incidence of HIV and HSV-2, and associated risk factors.Women aged 18-44 years working in food and recreational facilities were screened to determine their eligibility for the studies. Between 2008-2010, HIV-negative women were enrolled and followed for 12 months. At enrolment and 3-monthly, we collected socio-demographic and behavioural data, and performed clinical examinations for collection of biological specimens that were tested for reproductive tract infections. Risk factors for HIV and HSV-2 incidence were investigated using Poisson regression models.We screened 2,229 and enrolled 1,378 women. The median age was 27 years (interquartile range, IQR 22, 33), and median duration working at current facility was 2 years. The prevalences of HIV at screening and HSV-2 at enrolment were 16% and 67%, respectively. Attendance at the 12-month visit was 86%. HIV and HSV-2 incidence rates were 3.7 (95% confidence interval, CI: 2.8,5.1) and 28.6 (95% CI: 23.5,35.0)/100 person-years, respectively. Women who were separated, divorced, or widowed were at increased risk of HIV (adjusted incidence rate ratio, aRR = 6.63; 95% CI: 1.97,22.2) and HSV-2 (aRR = 2.00; 95% CI: 1.15,3.47) compared with married women. Women reporting ≥3 partners in the past 3 months were at higher HIV risk compared with women with 0-1 partner (aRR = 4.75; 95% CI: 2.10,10.8), while those who had reached secondary education or above were at lower risk of HSV-2 compared with women with incomplete primary education (aRR = 0.42; 95% CI: 0.22,0.82).HIV and HSV-2 rates remain substantially higher in this cohort than in the general population, indicating urgent need for effective interventions. These studies demonstrate the feasibility of conducting trials to test new interventions in this highly-mobile population.
url http://europepmc.org/articles/PMC3715536?pdf=render
work_keys_str_mv AT saidihkapiga theepidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT fionamewings theepidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT tonyao theepidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT josephchilongani theepidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT aikamongi theepidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT kathybaisley theepidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT suzannafrancis theepidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT auraandreasen theepidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT ramadhanhashim theepidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT deborahwatsonjones theepidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT johnchangalucha theepidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT richardhayes theepidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT saidihkapiga epidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT fionamewings epidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT tonyao epidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT josephchilongani epidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT aikamongi epidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT kathybaisley epidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT suzannafrancis epidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT auraandreasen epidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT ramadhanhashim epidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT deborahwatsonjones epidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT johnchangalucha epidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
AT richardhayes epidemiologyofhivandhsv2infectionsamongwomenparticipatinginmicrobicideandvaccinefeasibilitystudiesinnortherntanzania
_version_ 1725089733597462528